Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer

NCT05770063 — Not applicable, Unknown, 86 participants, Beijing Chest Hospital

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Registry	NCT05770063
Status	Unknown
Phase	Not applicable
Study type	Interventional; randomized, parallel, masking: quadruple, supportive care
Enrollment	86 (Estimated)
Sponsor	Beijing Chest Hospital (Other)
Conditions	Amino Acid Deficiency, Malnutrition, Lung Cancer
Interventions	amino acid tablet (Dietary supplement)
Dates	start 2023-04-15 (estimated), primary completion 2023-07-30 (estimated), completion 2023-08-30 (estimated), first posted 2023-03-15, last updated 2023-03-15

-Summary

To investigate whether compound amino acid supplementation can further promote protein synthesis and improve nutritional status for lung cancer patients.

Expand all sections · Collapse all

+Arms and interventions

Arm	Type	Interventions	Description
intervention group	Experimental	Dietary Supplement: amino acid tablet	compound amino acid supplement
control group	Placebo comparator	Dietary Supplement: amino acid tablet	placebo

amino acid tablet (Dietary supplement): multiple essential amino acids supplements

+Outcome measures

Primary outcomes

Concentration of albumin [after 42 days after the intervention]

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* NRS2002 >=3 scores
* lung cancer patients
* low albumin or hemoglobin
* informed consent

Exclusion Criteria:

* Acute and critical patients;
* Severe liver and kidney dysfunction;
* Patients with gastrointestinal bleeding or intestinal obstruction;
* Pregnant women, lactating women, people with mental illness, and people without independent behavior ability.